LEADER 3—Lipase and Amylase Activity in Subjects With Type 2 Diabetes: Baseline Data From Over 9000 Subjects in the LEADER Trial

OBJECTIVES: This report from the LEADER (Liraglutide Effect and Action in Diabetes: Evaluation of Cardiovascular Outcome Results) trial describes baseline lipase and amylase activity in type 2 diabetic subjects without acute pancreatitis symptoms before randomization to the glucagonlike peptide anal...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Hoofdauteurs: Steinberg, William M., Nauck, Michael A., Zinman, Bernard, Daniels, Gilbert H., Bergenstal, Richard M., Mann, Johannes F.E., Steen Ravn, Lasse, Moses, Alan C., Stockner, Mette, Baeres, Florian M.M., Marso, Steven P., Buse, John B.
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: Lippincott Williams & Wilkins 2014
Onderwerpen:
Original Articles
Online toegang:https://ncbi.nlm.nih.gov/pmc/articles/PMC4206347/
https://ncbi.nlm.nih.gov/pubmed/25275271
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/MPA.0000000000000229
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!

Gelijkaardige items